The negative correlation between KLHL23 expression and immune/stromal cell infiltration suggests that increased KLHL23 levels could be associated with a less active immune environment within the tumor, which may have implications for the effectiveness of immunotherapy and other treatments relying on the body’s immune response to combat cancer cells. Here, KLHL23 is linked to cancer.